Ep. 148 How MedVector Is Fixing Patient Recruitment in Clinical Trials with Scott Stout

Show Notes:In this episode of Business Growth Spotlight, host Heidi Schalk sits down with Scott Stout, CEO of MedVector, to unpack one of the biggest bottlenecks in modern medicine. Patient recruitment for clinical trials.Scott shares how outdated recruitment methods like billboards and generic digital ads are slowing innovation and delaying life changing treatments by years. He explains the complex tension between FDA requirements and HIPAA privacy laws and why this has created a broken multibillion dollar sub industry.You will learn how MedVector is rethinking the entire clinical trial model by putting physicians back at the center of the process and leveraging telemedicine to unlock access, improve diversity, and dramatically reduce patient leakage. Scott also walks through his unconventional journey from finance and wealth management into healthcare innovation and how one simple question sparked the creation of MedVector.This conversation dives into decentralized clinical trials, the cultural resistance within pharma, why adoption is harder than technology, and what the next three to five years will look like for remote and hybrid trial models.If you are interested in healthcare innovation, clinical research, patient access, or scaling a marketplace driven business, this episode offers powerful insights from the front lines.Bio: Scott Stout is the Founder & CEO of MedVector, a company revolutionizing how clinical trial sites collaborate with local doctors. The result unlocks access to advanced medicine for millions of patients otherwise trapped behind treating physicians who don't refer patients to clinical trials.To connect with our guest, click on the links below:LinkedIn:  https://www.linkedin.com/in/scott-stout-01992653/Website:  www.MedVector.comConnect with me:LinkedIn:  https://www.linkedin.com/in/heidischalkcoaching/